Our results are consistent with other studies showing that another curcumin analog, ASC-J9, induces MDM2-mediated AR ubiquitination to inhibit prostate cancer [20], suggesting that AR is a critical player for anti-cancer effects of curcumin and its analogs. The gene discussed is MDM2; the disease is prostate carcinoma.